Splitomicin, Sirtinol and ILS-JGB-1741 are the inhibitor drugs used to inhibit the expression of SIRT1 in BC cells, which have been shown to inhibit cell proliferation, induce cell cycle arrest and apoptosis (20, 24). This evidence concerns the gene SIRT1 and breast cancer.